Abstract:Nephrotoxicity is a major side effect of cisplatin, a widely used cancer therapy drug. Depending on its concentration, cisplatin induces necrosis or apoptosis of tubular cells in the kidneys, whereas the underlying injury mechanism is unclear. Our recent work has suggested a critical role for p53 in cisplatin-induced tubular cell apoptosis; nevertheless, the apoptotic events triggered by p53 remain elusive. The current study has examined Bcl-2 family proteins, critical regulators of apoptosis that may be subjected to p53 regulation. Following cisplatin treatment, the expression of Bcl-xL, an antiapoptotic molecule, was suppressed, while the expression of Bak, a proapoptotic molecule, increased slightly. Of interest, PUMA- α , a newly identified p53-responsive proapoptotic Bcl-2 family protein, was drastically induced by cisplatin. PUMA- α induction preceded or paralleled the development of apoptosis. Induced PUMA- α was localized in mitochondria and appeared to antagonize Bcl-xL via molecular interaction. PUMA- α induction during cisplatin treatment was attenuated by pifithrin- α , a pharmacological inhibitor of p53, which was accompanied by the amelioration of Bax activation, cytochrome c release and apoptosis. Moreover, PUMA- α induction was suppressed by dominant-negative p53. Importantly, cisplatin-induced apoptosis was ameliorated in PUMA- α knockout cells. In vivo , cisplatin induced PUMA- α in the kidneys, and the inductive response was abrogated in p53-deficient animals. Together, this study has demonstrated the first compelling evidence for the involvement of PUMA- α in p53-mediated renal cell apoptosis during cisplatin nephrotoxicity.

The Expression of PUMA in Colon Carcinoma Cells and Its Effect in Cell Apoptosis

Polyunsaturated Fatty Acids Trigger Apoptosis of Colon Cancer Cells Through a Mitochondrial Pathway.

Polyunsaturated Fatty Acids Augment Tumoricidal Action Of 5-Fluorouracil On Gastric Cancer Cells By Their Action On Vascular Endothelial Growth Factor, Tumor Necrosis Factor-Alpha And Lipid Metabolism Related Factors

PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells

The BH3-only Protein, PUMA, is Involved in Oxaliplatin-Induced Apoptosis in Colon Cancer Cells

Possible Mechanisms of Acquired Resistance to 5-FU in Human Colon Cancer

PUMA, a potent killer with or without p53

Apoptotic Effects of the Exogenous PTEN Tumor Suppressor Gene on Human Mucoepidermoid Carcinoma Cell Line

Effect of PUMA on sensitivity of drug resistant choriocarcinoma cells to chemotherapeutic agents

The Role of PUMA in Oxaliplatin-Induced Apoptosis in Colon Cancer Cells

P53 up-regulated modulator of apoptosis in gastric carcinoma

Advance in PUMA and Cardiomyocyte Apoptosis

PUMA: a New Target in Cytoprotective and Tumor Therapy

Puma Overexpression Induces Reactive Oxygen Species Generation And Proteasome-Mediated Stathmin Degradation In Colorectal Cancer Cells

Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA

Chemotherapy mediates intestinal injury via p53/p53 upregulated modulator of apoptosis (PUMA) signaling pathway

Autophagic Cell Death Induced by 5-FU in Bax or PUMA Deficient Human Colon Cancer Cell.

A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA.

The Nuclear Function of P53 is Required for Puma-Mediated Apoptosis Induced by Dna Damage

Effect of P53 Gene Expression on Apoptosis of K562 Cellsinduced by Ubenimex

Regulation of PUMA- α by p53 in cisplatin-induced renal cell apoptosis